| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue | 228 | 674 | 645 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 228 | 674 | 645 | | | Operating Expenses | | Research Development | 7,777 | 9,325 | 5,761 | | Selling General and Administrative | 3,630 | 3,756 | 8,703 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (11,179) | (12,407) | (13,819) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (11,179) | (12,407) | (13,819) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (11,179) | (12,407) | (13,819) | | Income Tax Expense | 1 | 3 | 1 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,180) | (12,410) | (13,820) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,180) | (12,410) | (13,820) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,180) | ($12,410) | ($13,820) |
|
0.29% Nasdaq 
Income Statement
